Rare Diseases Q3 2025 | A promotional supplement distributed on behalf of Mediaplanet, which takes sole responsibility for its content
www.healthawareness.co.uk
“95% of rare conditions have no approved treatment, and those that do exist are often expensive and hard to access.”
“Rare diseases sit at the crossroads of the challenges that national and regional competitiveness strategies aim to solve.”
Debra Bellon, Strategic Engagement Manager, Rare Diseases International
Rosa Castro, Public Affairs Director, EURORDIS-Rare Diseases Europe
Page 02
Page 06